Advanced search
Publication Cover
Epigenetics Volume 8, 2013 - Issue 9
Submit an article Journal homepage
925
Views
24
CrossRef citations to date
0
Altmetric
Brief Report

RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma

Seley Gharanei Centre for Rare Diseases and Personalized Medicine; School of Clinical and Experimental Medicine; University of Birmingham; Birmingham, UK
,
Anna T Brini Department of Biomedical, Surgical, and Dental Sciences; University of Milan; Milan, Italy; I.R.C.S.S. Istituto Ortopedico Galeazzi; Milan, Italy
,
Sumathi Vaiyapuri Royal Orthopaedic Hospital Foundation Trust; Robert Aitken Institute of Clinical Research; University of Birmingham; Birmingham, UK
,
Abdullah Alholle Centre for Rare Diseases and Personalized Medicine; School of Clinical and Experimental Medicine; University of Birmingham; Birmingham, UK
,
Ashraf Dallol Center of Excellence in Genomic Medicine Research and KACST Technology Innovation Center in Personalized Medicine; King Abdulaziz University; Jeddah, Kingdom of Saudi Arabia
,
Elena Arrigoni Department of Biomedical, Surgical, and Dental Sciences; University of Milan; Milan, Italy
,
Takeshi Kishida Department Of Urology; Kanagawa Cancer Center; Yokohama, Japan
,
Toru Hiruma Department of Musculoskeletal tumor surgery; Kanagawa Cancer Center; Kanagawa, Japan
,
Smadar Avigad Felsenstein Medical Research Center; Pediatric Hematology Oncology; Schneider Children’s Medical Center of Israel; Petah Tikva, Israel
,
Robert Grimer Royal Orthopaedic Hospital Foundation Trust; Robert Aitken Institute of Clinical Research; University of Birmingham; Birmingham, UK
,
Eamonn R Maher Centre for Rare Diseases and Personalized Medicine; School of Clinical and Experimental Medicine; University of Birmingham; Birmingham, UK
&
Farida Latif Centre for Rare Diseases and Personalized Medicine; School of Clinical and Experimental Medicine; University of Birmingham; Birmingham, UKCorrespondence[email protected]
 show all
Pages 893-898 | Received 01 May 2013, Accepted 03 Jul 2013, Published online: 18 Jul 2013

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Kun Li, Fengmei Han, Yanping Wu & Xue Wang. (2021) miR-340 Promotes Retinoblastoma Cell Proliferation, Migration and Invasion Through Targeting WIF1. OncoTargets and Therapy 14, pages 3635-3648.
Read now
A Alholle, A T Brini, J Bauer, S Gharanei, S Niada, A Slater, D Gentle, E R Maher, L Jeys, R Grimer, V P Sumathi & F Latif. (2015) Genome-wide DNA methylation profiling of recurrent and non-recurrent chordomas . Epigenetics 10:3, pages 213-220.
Read now
Abdullah Alholle, Anna T Brini, Seley Gharanei, Sumathi Vaiyapuri, Elena Arrigoni, Ashraf Dallol, Dean Gentle, Takeshi Kishida, Toru Hiruma, Smadar Avigad, Robert Grimer, Eamonn R Maher & Farida Latif. (2013) Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma. Epigenetics 8:11, pages 1198-1204.
Read now

Articles from other publishers (21)

Carmen Salguero-Aranda, Joaquín Olmedo-Pelayo, Enrique de Álava, Ana Teresa Amaral & Juan Díaz-Martín. (2022) Genetic Alterations and Deregulation of Hippo Pathway as a Pathogenetic Mechanism in Bone and Soft Tissue Sarcoma. Cancers 14:24, pages 6211.
Crossref
Camilla Cristalli, Maria Cristina Manara, Sergio Valente, Evelin Pellegrini, Alberto Bavelloni, Alessandra De Feo, William Blalock, Elisabetta Di Bello, David Piñeyro, Angelika Merkel, Manel Esteller, Oscar M. Tirado, Antonello Mai & Katia Scotlandi. (2022) Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response. Frontiers in Endocrinology 13.
Crossref
Howard Donninger & Geoffrey J. Clark. 2022. Tumor Suppressor Par-4. Tumor Suppressor Par-4 253 262 .
Filomena de Nigris, Carlo Ruosi & Claudio Napoli. (2021) Clinical efficiency of epigenetic drugs therapy in bone malignancies. Bone 143, pages 115605.
Crossref
P. Gargallo, A. Juan, Y. Yáñez, S. Dolz, V. Segura, V. Castel & A. Cañete. (2020) Precision medicine in Ewing sarcoma: a translational point of view. Clinical and Translational Oncology 22:9, pages 1440-1454.
Crossref
Heinrich Kovar, Lisa Bierbaumer & Branka Radic-Sarikas. (2020) The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis. Cells 9:4, pages 972.
Crossref
Pablo Rodríguez‐Núñez, Laura Romero‐Pérez, Ana T Amaral, Pilar Puerto‐Camacho, Carmen Jordán, David Marcilla, Thomas GP Grünewald, Javier Alonso, Enrique Alava & Juan Díaz‐Martín. (2020) Hippo pathway effectors YAP1/TAZ induce an EWS–FLI1 ‐opposing gene signature and associate with disease progression in Ewing sarcoma . The Journal of Pathology 250:4, pages 374-386.
Crossref
Christian Smolle, Lukas A. Holzer, Maria Anna Smolle, Kinga Szurian, Christian Viertler, Koppany Bodo, Bernadette Liegl-Atzwanger & Andreas Leithner. (2019) Differences in intraosseous and extraosseous post-chemotherapy regression of Ewing sarcomas and their influence on prognosis. Pathology - Research and Practice 215:10, pages 152613.
Crossref
Anastasios Kyriazoglou, Roubini Zakopoulou, Flora Zagouri, Aristotelis Bamias & Meletios Athanasios Dimopoulos. (2019) Clinical and biological implications of Hippo pathway dysregulation in sarcomas. Forum of Clinical Oncology 9:1, pages 11-16.
Crossref
Laetitia Michou. (2018) Epigenetics of bone diseases. Joint Bone Spine 85:6, pages 701-707.
Crossref
Laëtitia Michou. (2018) Épigénétique des maladies osseuses. Revue du Rhumatisme 85:5, pages 453-459.
Crossref
D. Aydin, A. Bilici, S. Kayahan, D. Yavuzer, M. Basar & M. Aliustaoglu. (2015) Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy. Clinical and Translational Oncology 18:6, pages 608-616.
Crossref
Thibaut Barnoud, Daniel Wilkey, Michael Merchant, Jennifer Clark & Howard Donninger. (2016) Proteomics Analysis Reveals Novel RASSF2 Interaction Partners. Cancers 8:3, pages 37.
Crossref
. 2016. Diagnostic Pathology: Molecular Oncology. Diagnostic Pathology: Molecular Oncology 8-296 8-301 .
Wei Guo, Zhiming Dong, Jianli Cui, Yanli Guo, Supeng Shen, Xin Guo & Gang Kuang. (2015) Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma. Clinical & Experimental Metastasis 33:1, pages 73-85.
Crossref
Noemi Perez-Janices, Idoia Blanco-Luquin, Natalia Torrea, Therese Liechtenstein, David Escors, Alicia Cordoba, Francisco Vicente-Garcia, Isabel Jauregui, Susana De La Cruz, José Juan Illarramendi, Valle Coca, Maria Berdasco, Grazyna Kochan, Berta Ibañez, José Miguel Lera & David Guerrero-Setas. (2015) Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis . Oncotarget 6:27, pages 23944-23958.
Crossref
Michael D. Deel, Jenny J. Li, Lisa E. S. Crose & Corinne M. Linardic. (2015) A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas. Frontiers in Oncology 5.
Crossref
Rocio K. Rivera-Valentin, Limin Zhu & Dennis P. M. Hughes. (2015) Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy. Pediatric Drugs 17:4, pages 257-271.
Crossref
S. B. Roberts, E. Wootton, L. De Ferrari, O. M. Albagha & D. M. Salter. (2015) Epigenetics of osteoarticular diseases: recent developments. Rheumatology International 35:8, pages 1293-1305.
Crossref
Noemi Perez-Janices, Idoia Blanco-Luquin, Maria Teresa Tuñón, Edurne Barba-Ramos, Berta Ibáñez, Idoya Zazpe-Cenoz, Maria Teresa Martinez-Aguillo, Berta Hernandez, Enrique Martínez-Lopez, Agustin F. Fernández, Maria Roasario Mercado, Teresa Cabada, David Escors, Diego Megias & David Guerrero-Setas. (2015) EPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas. Oncotarget 6:1, pages 368-380.
Crossref
Jared R. Mortus, Yi Zhang & Dennis P. M. Hughes. 2014. Current Advances in Osteosarcoma. Current Advances in Osteosarcoma 93 118 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.